Trial Profile
A Phase 1, Open-Label Study to Evaluate the Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 May 2018
Price :
$35
*
At a glance
- Drugs Brilanestrant (Primary) ; Pravastatin (Primary)
- Indications Breast cancer
- Focus Pharmacokinetics
- Sponsors Genentech
- 22 May 2018 Results published in the Journal of Clinical Pharmacology
- 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 01 Mar 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.